Pressrelease – Lund, October 28th, 2026 – Invitation to Hamlet BioPharma’s monthly digital meeting on October 30th, 2026

Hamlet Biopharma
|
October 28, 2026
An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.
Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958
Subscribe to receive
Pressreleases and Newsletters
© 2026
Hamlet BioPharma.